Senseonics Holdings, Inc. to Participate in Upcoming Conferences
May 02 2024 - 8:05AM
Business Wire
Senseonics Holdings, Inc. (NYSE American: SENS), a medical
technology company focused on the development and manufacturing of
long-term, implantable continuous glucose monitoring (CGM) systems
for people with diabetes, today announced plans to participate in
the upcoming RBC Capital Markets Global Healthcare Conference and
the H.C. Wainwright 2nd Annual BioConnect Investor Conference,
being held in New York, NY.
Management is scheduled to participate in the RBC Capital
Markets Global Healthcare Conference on Wednesday, May 15, 2024, at
3:35pm ET and will hold one-on-one meetings.
Management is scheduled to participate in the H.C. Wainwright
2nd Annual BioConnect Investor Conference on Monday, May 20, 2024,
at 4:00pm ET and will hold one-on-one meetings.
Interested parties may access a live and recorded webcast of the
presentation on the “Investor Relations” section of the company’s
website at www.senseonics.com.
About Senseonics
Senseonics Holdings, Inc. (“Senseonics”) is a medical technology
company focused on the development and manufacturing of glucose
monitoring products designed to transform lives in the global
diabetes community with differentiated, long-term implantable
glucose management technology. Senseonics’ CGM system Eversense® E3
includes a small sensor inserted completely under the skin that
communicates with a smart transmitter worn over the sensor. The
glucose data are automatically sent every 5 minutes to a mobile app
on the user’s smartphone.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240502567146/en/
Senseonics Investor Contact Philip Taylor Gilmartin Group
415-937-5406 Investors@senseonics.com
Senseonics (AMEX:SENS)
Historical Stock Chart
From Sep 2024 to Oct 2024
Senseonics (AMEX:SENS)
Historical Stock Chart
From Oct 2023 to Oct 2024